Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors

Board expansion strengthens governance, strategic leadership, and capital markets engagement as Immorta Bio advances toward the clinic MIAMI, May 21, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company focused on Treating Diseases of Aging and Treating Aging as Disease™,...